Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1999 Sep;58(9):525–529. doi: 10.1136/ard.58.9.525

Does social disadvantage contribute to the excess mortality in rheumatoid arthritis patients?

N Maiden 1, H Capell 1, R Madhok 1, R Hampson 1, E Thomson 1
PMCID: PMC1752941  PMID: 10460184

Abstract

BACKGROUND—Socioeconomic deprivation is associated with increased mortality from cardiovascular causes and malignancy. The influence of disadvantage in patients with rheumatoid arthritis (RA), who are known to have premature mortality, has not been ascertained.
AIM—To assess the relation between the level of patient deprivation and mortality in RA patients.
METHODS—200 RA patients, enrolled in a study comparing sulfasalazine and penicillamine in 1984-85, have been followed up prospectively for 12 years. Subjects were categorised into Carstairs groups with deprivation scores ranging from 1 (most affluent) to 7 (most deprived). Information about deaths was obtained from the Registrar General in Scotland, death certificates and GP/hospital records.
RESULTS—There were more RA patients in the deprived areas then expected compared with the West of Scotland and England and Wales. Some 47.5% of the RA patients had died by 12 years—the majority of cardiorespiratory causes or malignancy. There were no differences in the median age or disease duration in the various Carstairs groups at study entry, but the percentage of deaths was higher in the more deprived groups after 12 years (36% dead in most affluent area compared with 61% in the most deprived, that is, in groups 6 and 7).
CONCLUSION—In patients with RA increasing deprivation was associated with premature mortality. If confirmed elsewhere these findings have implications for rheumatological management strategies, for researchers involved in collaborative studies of patients from different socioeconomic backgrounds and for resource allocation.



Full Text

The Full Text of this article is available as a PDF (74.7 KB).

Figure 1  .

Figure 1  

Open in a new tab

Twelve year survival curves by deprivation category.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angell M. Privilege and health--what is the connection? N Engl J Med. 1993 Jul 8;329(2):126–127. doi: 10.1056/NEJM199307083290210. [DOI] [PubMed] [Google Scholar]
  2. Black D. Deprivation and health. Chadwick Lecture 1996. J R Coll Physicians Lond. 1996 Sep-Oct;30(5):466–471. [PMC free article] [PubMed] [Google Scholar]
  3. Callahan L. F., Pincus T. Education, self-care, and outcomes of rheumatic diseases: further challenges to the "biomedical model" paradigm. Arthritis Care Res. 1997 Oct;10(5):283–288. doi: 10.1002/art.1790100502. [DOI] [PubMed] [Google Scholar]
  4. Callahan L. F., Pincus T. Formal education level as a significant marker of clinical status in rheumatoid arthritis. Arthritis Rheum. 1988 Nov;31(11):1346–1357. doi: 10.1002/art.1780311102. [DOI] [PubMed] [Google Scholar]
  5. Capell H. A., Maiden N., Madhok R., Hampson R., Thomson E. A. Intention-to-treat analysis of 200 patients with rheumatoid arthritis 12 years after random allocation to either sulfasalazine or penicillamine. J Rheumatol. 1998 Oct;25(10):1880–1886. [PubMed] [Google Scholar]
  6. Eames M., Ben-Shlomo Y., Marmot M. G. Social deprivation and premature mortality: regional comparison across England. BMJ. 1993 Oct 30;307(6912):1097–1102. doi: 10.1136/bmj.307.6912.1097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Epstein A. M., Stern R. S., Weissman J. S. Do the poor cost more? A multihospital study of patients' socioeconomic status and use of hospital resources. N Engl J Med. 1990 Apr 19;322(16):1122–1128. doi: 10.1056/NEJM199004193221606. [DOI] [PubMed] [Google Scholar]
  8. Fries J. F., Spitz P., Kraines R. G., Holman H. R. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980 Feb;23(2):137–145. doi: 10.1002/art.1780230202. [DOI] [PubMed] [Google Scholar]
  9. Heliövaara M., Aho K., Aromaa A., Knekt P., Reunanen A. Smoking and risk of rheumatoid arthritis. J Rheumatol. 1993 Nov;20(11):1830–1835. [PubMed] [Google Scholar]
  10. Leigh J. P., Fries J. F. Mortality predictors among 263 patients with rheumatoid arthritis. J Rheumatol. 1991 Sep;18(9):1307–1312. [PubMed] [Google Scholar]
  11. Linos A., Worthington J. W., O'Fallon W. M., Kurland L. T. The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. Am J Epidemiol. 1980 Jan;111(1):87–98. doi: 10.1093/oxfordjournals.aje.a112878. [DOI] [PubMed] [Google Scholar]
  12. McCarron P. G., Smith G. D., Womersley J. J. Deprivation and mortality in Glasgow: changes from 1980 to 1992. BMJ. 1994 Dec 3;309(6967):1481–1482. doi: 10.1136/bmj.309.6967.1481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. McEntegart A., Morrison E., Capell H. A., Duncan M. R., Porter D., Madhok R., Thomson E. A. Effect of social deprivation on disease severity and outcome in patients with rheumatoid arthritis. Ann Rheum Dis. 1997 Jul;56(7):410–413. doi: 10.1136/ard.56.7.410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. McLoone P., Boddy F. A. Deprivation and mortality in Scotland, 1981 and 1991. BMJ. 1994 Dec 3;309(6967):1465–1470. doi: 10.1136/bmj.309.6967.1465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Mitchell D. M., Spitz P. W., Young D. Y., Bloch D. A., McShane D. J., Fries J. F. Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis Rheum. 1986 Jun;29(6):706–714. doi: 10.1002/art.1780290602. [DOI] [PubMed] [Google Scholar]
  16. Mutru O., Laakso M., Isomäki H., Koota K. Ten year mortality and causes of death in patients with rheumatoid arthritis. Br Med J (Clin Res Ed) 1985 Jun 15;290(6484):1797–1799. doi: 10.1136/bmj.290.6484.1797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Myllykangas-Luosujärvi R., Aho K., Isomäki H. Death attributed to antirheumatic medication in a nationwide series of 1666 patients with rheumatoid arthritis who have died. J Rheumatol. 1995 Dec;22(12):2214–2217. [PubMed] [Google Scholar]
  18. Myllykangas-Luosujärvi R., Aho K., Isomäki H. Mortality from cancer in patients with rheumatoid arthritis. Scand J Rheumatol. 1995;24(2):76–78. doi: 10.3109/03009749509099288. [DOI] [PubMed] [Google Scholar]
  19. Myllykangas-Luosujärvi R., Aho K., Kautiainen H., Isomäki H. Cardiovascular mortality in women with rheumatoid arthritis. J Rheumatol. 1995 Jun;22(6):1065–1067. [PubMed] [Google Scholar]
  20. Pincus T., Callahan L. F., Burkhauser R. V. Most chronic diseases are reported more frequently by individuals with fewer than 12 years of formal education in the age 18-64 United States population. J Chronic Dis. 1987;40(9):865–874. doi: 10.1016/0021-9681(87)90186-x. [DOI] [PubMed] [Google Scholar]
  21. Pincus T., Callahan L. F. Remodeling the pyramid or remodeling the paradigms concerning rheumatoid arthritis--lessons from Hodgkin's disease and coronary artery disease. J Rheumatol. 1990 Dec;17(12):1582–1585. [PubMed] [Google Scholar]
  22. Pincus T., Callahan L. F. Rheumatology function tests: grip strength, walking time, button test and questionnaires document and predict longterm morbidity and mortality in rheumatoid arthritis. J Rheumatol. 1992 Jul;19(7):1051–1057. [PubMed] [Google Scholar]
  23. Porter D. R., Capell H. A., McInnes I., Munro R., Madhok R., Hunter J. A., Thomson E. A. Is rheumatoid arthritis becoming a milder disease? Or are we starting second-line therapy in patients with milder disease? Br J Rheumatol. 1996 Dec;35(12):1305–1308. doi: 10.1093/rheumatology/35.12.1305. [DOI] [PubMed] [Google Scholar]
  24. Prior P., Symmons D. P., Scott D. L., Brown R., Hawkins C. F. Cause of death in rheumatoid arthritis. Br J Rheumatol. 1984 May;23(2):92–99. doi: 10.1093/rheumatology/23.2.92. [DOI] [PubMed] [Google Scholar]
  25. Rasker J. J., Cosh J. A. Cause and age at death in a prospective study of 100 patients with rheumatoid arthritis. Ann Rheum Dis. 1981 Apr;40(2):115–120. doi: 10.1136/ard.40.2.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Rasker J. J., Cosh J. A. Course and prognosis of early rheumatoid arthritis. Scand J Rheumatol Suppl. 1989;79:45–56. doi: 10.3109/03009748909092612. [DOI] [PubMed] [Google Scholar]
  27. Rasker J. J., Cosh J. A. The natural history of rheumatoid arthritis: a fifteen year follow-up study. The prognostic significance of features noted in the first year. Clin Rheumatol. 1984 Mar;3(1):11–20. doi: 10.1007/BF02715690. [DOI] [PubMed] [Google Scholar]
  28. Raynauld J. P. Cardiovascular mortality in rheumatoid arthritis: how harmful are corticosteroids? J Rheumatol. 1997 Mar;24(3):415–416. [PubMed] [Google Scholar]
  29. Silman A., Davies P., Currey H. L., Evans S. J. Is rheumatoid arthritis becoming less severe? J Chronic Dis. 1983;36(12):891–897. doi: 10.1016/0021-9681(83)90011-5. [DOI] [PubMed] [Google Scholar]
  30. Sloggett A., Joshi H. Higher mortality in deprived areas: community or personal disadvantage? BMJ. 1994 Dec 3;309(6967):1470–1474. doi: 10.1136/bmj.309.6967.1470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Smith G. D., Hart C., Blane D., Gillis C., Hawthorne V. Lifetime socioeconomic position and mortality: prospective observational study. BMJ. 1997 Feb 22;314(7080):547–552. doi: 10.1136/bmj.314.7080.547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Smith R. Gap between death rates of rich and poor widens. BMJ. 1997 Jan 4;314(7073):9–9. [PMC free article] [PubMed] [Google Scholar]
  33. Vandenbroucke J. P., Hazevoet H. M., Cats A. Survival and cause of death in rheumatoid arthritis: a 25-year prospective followup. J Rheumatol. 1984 Apr;11(2):158–161. [PubMed] [Google Scholar]
  34. Vliet Vlieland T. P., Buitenhuis N. A., van Zeben D., Vandenbroucke J. P., Breedveld F. C., Hazes J. M. Sociodemographic factors and the outcome of rheumatoid arthritis in young women. Ann Rheum Dis. 1994 Dec;53(12):803–806. doi: 10.1136/ard.53.12.803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Wallberg-Jonsson S., Ohman M. L., Dahlqvist S. R. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol. 1997 Mar;24(3):445–451. [PubMed] [Google Scholar]
  36. Wild S., McKeigue P. Cross sectional analysis of mortality by country of birth in England and Wales, 1970-92. BMJ. 1997 Mar 8;314(7082):705–710. doi: 10.1136/bmj.314.7082.705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Wolfe F., Mitchell D. M., Sibley J. T., Fries J. F., Bloch D. A., Williams C. A., Spitz P. W., Haga M., Kleinheksel S. M., Cathey M. A. The mortality of rheumatoid arthritis. Arthritis Rheum. 1994 Apr;37(4):481–494. doi: 10.1002/art.1780370408. [DOI] [PubMed] [Google Scholar]
  38. Worrall A., Rea J. N., Ben-Shlomo Y. Counting the cost of social disadvantage in primary care: retrospective analysis of patient data. BMJ. 1997 Jan 4;314(7073):38–42. doi: 10.1136/bmj.314.7073.38. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES